Why the study?
Does sustained delivery of cenderitide via biodegradable films inhibit proliferation of hypertrophic human cardiac fibroblasts compared to daily infusion?
Does sustained delivery of cenderitide via biodegradable films inhibit proliferation of hypertrophic human cardiac fibroblasts compared to daily infusion?
Cenderitide-eluting films provide sustained peptide release that effectively inhibits human cardiac fibroblast proliferation in vitro, suggesting potential utility as cardiac patches to reduce remodeling.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ng et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: